English | Español
Press release submission | Nov 7, 2018

PROMIS NEUROSCIENCES, INC: Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer’s Disease
Press release submission | Nov 7, 2018

PARTNER THERAPEUTICS: Receives FDA Orphan Drug Designation for Leukine® for the Treatment of Pulmonary Alveolar Proteinosis
Press release submission | Nov 4, 2018

ALKERMES: Reports on Outcome of FDA Advisory Committee Meeting on ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
Press release submission | Nov 4, 2018

U.S. FOOD AND DRUG ADMINISTRATION: FDA permits marketing of two devices that detect parathyroid tissue in real-time during surgery
Press release submission | Oct 26, 2018

ABBVIE: To Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
Press release submission | Oct 26, 2018

ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
Karen Kidd | Oct 23, 2018

Think tank founder recommends standard patents over intellectual property rights to cut drug prices

Press release submission | Oct 18, 2018

AMERICAN BRAIN TUMOR ASSOCIATION: Launches 2018 Request for Grant Applications to Continue Driving Advances in the Brain Tumor Field

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access